Steroid Diabetes in Patients With Kidney Disease

Status Not yet recruiting

Clinical Trial Summary

If steroid diabetes is not recognized in time, it will cause irreversible damage to the body. Nephropathy patients are more likely to have steroid diabetes ,the incidence rate up to 25%,due to hypoalbuminemia, high-dose hormone and other reasons, so they need to be closely followed up, identified and intervened in time.

Clinical Trial Description

1. Patients with nephrosis who had taken glucocorticoid for the first time were followed up, and those who had diabetes themselves were excluded. 2. Regularly follow up and record information on glucocorticoid medication, medications that have an impact on blood sugar, fasting blood sugar, 2-hour postprandial blood sugar, and glycated hemoglobin. 3. Notify relevant doctors of any cases of elevated blood sugar. 4. The total follow-up time is 1 year. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06161701
Study type	Observational
Source	Zhejiang Provincial People's Hospital
Contact
Status	Not yet recruiting
Phase
Start date	January 1, 2024
Completion date	February 28, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02238418` - Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.	Phase 4
Completed	`NCT01895894` - Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome	Phase 4
Completed	`NCT01411982` - Role of PACAP in Nehprotic Syndrome	N/A
Recruiting	`NCT00308321` - Long Term Tapering or Standard Steroids for Nephrotic Syndrome	Phase 4
Active, not recruiting	`NCT03326037` - Study of The Association of Mutations in The NPHS2 Gene and Nephrotic Syndrome in Children and Adults in Middle East
Recruiting	`NCT01240564` - The Nephrotic Syndrome Study Network (NEPTUNE)	N/A
Completed	`NCT01252901` - Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases	N/A
Completed	`NCT01197040` - Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome	Phase 3
Terminated	`NCT00883636` - Cardiomyopathy in Steroid-resistant Nephrotic Syndrome: Impact of Focal Segmental Glomerulosclerosis	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Terminated	`NCT00004466` - Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome	Phase 2
Terminated	`NCT04558892` - Anti-Xa Activity of Enoxaparin for Prevention of Venous Thromboembolism in Severe Nephrotic Syndrome.	Phase 2/Phase 3
Completed	`NCT02257697` - A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome	Phase 3
Completed	`NCT00362531` - Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome	Phase 2/Phase 3
Completed	`NCT00289328` - Glucocorticoid-induced Osteopenia in Children	N/A
Recruiting	`NCT04759274` - Diuretic Tuner Clinical Decision Support	N/A
Completed	`NCT00001212` - Drug Therapy in Lupus Nephropathy	Phase 2
Recruiting	`NCT05623033` - The Predictive Value of Dynamic Changes of CD4+T Lymphocytes in Primary Nephrotic Syndrome With Infection
Completed	`NCT03332420` - The Efficacy of Huaiqihuang Granule in Children With Primary Nephrotic Syndrome
Not yet recruiting	`NCT05904197` - Effectiveness of Educational Gamified Cards About Nephrotic Syndrome	N/A